Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
Recruiting · NCT06576115 · Registry updated 2026-08-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer | Metastatic Pancreatic Adenocarcinoma | Recruiting | Phase 2 | 2026-08-10 | NCT06576115 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Barbara Ann Karmanos Cancer Institute | 29 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Karmanos Cancer Institute | Detroit | United States | 1 |
| Karmanos Cancer Institute at McLaren Clarkston | Clarkston | United States | 6 |
| Karmanos Cancer Institute at McLaren Flint | Flint | United States | 7 |
| Karmanos Cancer Institute at McLaren Greater Lansing | Lansing | United States | 55 |
| Karmanos Cancer Institute at McLaren Lapeer Region | Lapeer | United States | 4 |
| Karmanos Cancer Institute at McLaren Northern Michigan, Petoskey | Petoskey | United States | 3 |
| Karmanos Cancer Institute at McLaren Port Huron | Port Huron | United States | 6 |